Literature DB >> 17492503

Functional diagnostics in mitochondrial diseases.

Gabriele Siciliano1, Leda Volpi, Selina Piazza, Giulia Ricci, Michelangelo Mancuso, Luigi Murri.   

Abstract

Mitochondrial diseases (MD) with respiratory chain defects are caused by genetic mutations that determine an impairment of the electron transport chain functioning. Diagnosis often requires a complex approach with measurements of serum lactate, magnetic resonance spectroscopy (MRS), muscle histology and ultrastructure, enzymology, genetic analysis, and exercise testing. The ubiquitous distribution of the mitochondria in the human body explains the multiple organ involvement. Exercise intolerance is a common symptom of MD, due to increased dependence of skeletal muscle on anaerobic metabolism, with an excess lactate generation, phosphocreatine depletion, enhanced free radical production, reduced oxygen extraction and electron flux through the respiratory chain. MD treatment has included antioxidants (vitamin E, alpha lipoic acid), coenzyme Q10, riboflavin, creatine monohydrate, dichloroacetate and exercise training. Exercise is a particularly important tool in diagnosis as well as in the management of these diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17492503     DOI: 10.1007/s10540-007-9037-0

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  10 in total

1.  Coenzyme q10 and statin-induced mitochondrial dysfunction.

Authors:  Richard Deichmann; Carl Lavie; Samuel Andrews
Journal:  Ochsner J       Date:  2010

Review 2.  Metabolic myopathies: functional evaluation by different exercise testing approaches.

Authors:  L Volpi; G Ricci; D Orsucci; R Alessi; F Bertolucci; S Piazza; C Simoncini; M Mancuso; G Siciliano
Journal:  Musculoskelet Surg       Date:  2011-03-04

3.  Genetic ablation of calcium-independent phospholipase A2gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype.

Authors:  David J Mancuso; Harold F Sims; Xianlin Han; Christopher M Jenkins; Shao Ping Guan; Kui Yang; Sung Ho Moon; Terri Pietka; Nada A Abumrad; Paul H Schlesinger; Richard W Gross
Journal:  J Biol Chem       Date:  2007-10-08       Impact factor: 5.157

Review 4.  Vitamin C: update on physiology and pharmacology.

Authors:  J Mandl; A Szarka; G Bánhegyi
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

Review 5.  Cardiopulmonary exercise testing: relevant but underused.

Authors:  Daniel E Forman; Jonathan Myers; Carl J Lavie; Marco Guazzi; Bartolome Celli; Ross Arena
Journal:  Postgrad Med       Date:  2010-11       Impact factor: 4.379

6.  Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice.

Authors:  Xiaoqing Zhang; Hongyang Liu; Yuhua Hao; Lulu Xu; Tiemei Zhang; Yingshu Liu; Lipeng Guo; Liyue Zhu; Zuowei Pei
Journal:  Lipids Health Dis       Date:  2018-12-08       Impact factor: 3.876

7.  The Mechanism of Action of Ethoxidol on Oxidative Stress Indices in Heart Failure and Hypotension.

Authors:  V G Kukes; O K Parfenova; B K Romanov; A B Prokofiev; E V Parfenova; N G Sidorov; A A Gazdanova; L I Pavlova; V I Zozina; A D Andreev; T V Aleksandrova; S V Chernova; G V Ramenskaya
Journal:  Sovrem Tekhnologii Med       Date:  2020

8.  Effect of Coenzyme Q10 Supplementation in Statin-Treated Obese Rats.

Authors:  Hye-Kyung Choi; Eun-Kyung Won; Se-Young Choung
Journal:  Biomol Ther (Seoul)       Date:  2016-03-01       Impact factor: 4.634

Review 9.  Myopathology of Adult and Paediatric Mitochondrial Diseases.

Authors:  Rahul Phadke
Journal:  J Clin Med       Date:  2017-07-04       Impact factor: 4.241

10.  Exercise therapy in muscle diseases: open issues and future perspectives.

Authors:  Gabriele Siciliano; Erika Schirinzi; Costanza Simoncini; Giulia Ricci
Journal:  Acta Myol       Date:  2019-12-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.